These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11179382)

  • 1. Recognition of multiple antibody epitopes throughout Borrelia burgdorferi p66, a candidate adhesin, in patients with early or late manifestations of Lyme disease.
    Ntchobo H; Rothermel H; Chege W; Steere AC; Coburn J
    Infect Immun; 2001 Mar; 69(3):1953-6. PubMed ID: 11179382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.
    Kalish RA; Leong JM; Steere AC
    Infect Immun; 1995 Jun; 63(6):2228-35. PubMed ID: 7768602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.
    Embers ME; Jacobs MB; Johnson BJ; Philipp MT
    Clin Vaccine Immunol; 2007 Aug; 14(8):931-6. PubMed ID: 17567769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3.
    Coburn J; Cugini C
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7301-6. PubMed ID: 12748384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Reactive Epitopes in Borrelia burgdorferi p66.
    Arnaboldi PM; Dattwyler RJ
    Clin Vaccine Immunol; 2015 Jul; 22(7):840-3. PubMed ID: 25972406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
    Cinco M; Trevisan G; Agolzer A
    Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of amino acid domains of
    Curtis MW; Fierros CH; Hahn BL; Surdel MC; Kessler J; Anderson PN; Vandewalle-Capo M; Bonde M; Zhu J; Bergström S; Coburn J
    Front Cell Infect Microbiol; 2022; 12():991689. PubMed ID: 36211976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
    Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
    J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a candidate Borrelia burgdorferi beta3-chain integrin ligand identified using a phage display library.
    Coburn J; Chege W; Magoun L; Bodary SC; Leong JM
    Mol Microbiol; 1999 Dec; 34(5):926-40. PubMed ID: 10594819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
    Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
    J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of Borrelia burgdorferi p66 sequences required for integrin alpha(IIb)beta(3) recognition.
    Defoe G; Coburn J
    Infect Immun; 2001 May; 69(5):3455-9. PubMed ID: 11292775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal prevalence of antibodies against Borrelia burgdorferi in Białowieza inhabitants.
    Flisiak R; Wiercińska-Drapało A; Kalinowska A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):96-102. PubMed ID: 8673812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope.
    Brunner M; Stein S; Mitchell PD; Sigal LH
    J Clin Microbiol; 1998 Apr; 36(4):1074-80. PubMed ID: 9542940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P66 porins are present in both Lyme disease and relapsing fever spirochetes: a comparison of the biophysical properties of P66 porins from six Borrelia species.
    Bárcena-Uribarri I; Thein M; Sacher A; Bunikis I; Bonde M; Bergström S; Benz R
    Biochim Biophys Acta; 2010 Jun; 1798(6):1197-203. PubMed ID: 20188698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoblot analysis of antibody binding to polypeptides of Borrelia burgdorferi in children with different clinical manifestations of Lyme disease.
    Nadal D; Taverna C; Hitzig WH
    Pediatr Res; 1989 Oct; 26(4):377-82. PubMed ID: 2677950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.